Results of a study showing vitamin D deficiency among elderly patients with DLBCL can affect the efficacy of rituximab during CHOP-R treatment. Suggesting Vitamin D substitution be included with treatment regimens.
Home / Resource Library / Vitamin D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With but Not Without Rituximab